Dublin, Dec. 04, 2019 (GLOBE NEWSWIRE) -- The "Global Hematology Partnering 2014-2019: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
Global Hematology Partnering 2014 to 2019 provides the full collection of Hematology disease deals signed between the world's pharmaceutical and biotechnology companies since 2014.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Hematology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Hematology deals.
The report presents financial deal terms values for Hematology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The report includes deals for the following indications: Agranulocytosis, Anemia, Haemolytic, Iron deficiency, Blood substitute, Disseminated intravascular coagulation (DIC), Hemophilia, Immune thrombocytopenic purpura, Neutropenia, Polycythemia, Thalassemia, Thrombocytopenia, Vitamin K Deficiency, Von-Willebrand disease, plus other hematological indications.
Report scope
- Trends in Hematology dealmaking in the biopharma industry since 2014
- Analysis of Hematology deal structure
- Access to headline, upfront, milestone and royalty data
- Access to hundreds of Hematology deal contract documents
- Comprehensive access to over 200 Hematology deal records
- The leading Hematology deals by value since 2014
- Most active Hematology dealmakers since 2014
Available deals and contracts are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Stage of development at signing
- Deal component type
- Technology type
- Specific therapy indication
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in Hematology dealmaking
2.1. Introduction
2.2. Hematology partnering over the years
2.3. Hematology partnering by deal type
2.4. Hematology partnering by industry sector
2.5. Hematology partnering by stage of development
2.6. Hematology partnering by technology type
2.7. Hematology partnering by therapeutic indication
Chapter 3 -Financial deal terms for Hematology partnering
3.1. Introduction
3.2. Disclosed financials terms for Hematology partnering
3.3. Hematology partnering headline values
3.4. Hematology deal upfront payments
3.5. Hematology deal milestone payments
3.6. Hematology royalty rates
Chapter 4 - Leading Hematology deals and dealmakers
4.1. Introduction
4.2. Most active in Hematology partnering
4.3. List of most active dealmakers in Hematology
4.4. Top Hematology deals by value
Chapter 5 - Hematology contract document directory
5.1. Introduction
5.2. Hematology partnering deals where contract document available
Chapter 6 - Hematology dealmaking by therapeutic target
6.1. Introduction
6.2. Deals by Hematology therapeutic target
Appendices
Appendix 1 - Directory of Hematology deals by company A-Z 2014 to 2019
Appendix 2 - Directory of Hematology deals by deal type 2014 to 2019
Appendix 3 - Directory of Hematology deals by stage of development 2014 to 2019
Appendix 4 - Directory of Hematology deals by technology type 2014 to 2019
Companies Mentioned
- Abbott Laboratories
- Abzena
- Accord Healthcare
- Accuscience
- Acrotech Biopharma
- Advanced Biological Laboratories
- AffaMed Therapeutics
- AkaRx
- Akebia Therapeutics
- Akers Biosciences
- Akron Biotechnology
- Alchemia
- Alnylam Pharmaceuticals
- Alphamedix
- American society of Hematology
- Amgen
- Anthos Therapeutics
- Antitope
- Apceth
- Aplagon
- ApoPharma
- Aptevo Therapeutics
- APT Therapeutics
- ArcherDX
- Arch Therapeutics
- Armaghan Salamat Kish
- Armetheon
- Arsia Therapeutics
- Aruvant Sciences
- ASKA Pharmaceuticals
- Aspen Holding
- AstraZeneca
- Audaire Health
- AUT Roche Diagnostics Laboratory
- AUT University
- AVL Sofia
- Banc De Sang I Teixits
- Baxalta
- Baxter International
- Bayer
- Bayer Healthcare
- Baylor College of Medicine
- Beijing Leadman Biochemistry
- Belgian Red Cross
- Bicycle Therapeutics
- Bill and Melinda Gates Foundation
- Biocept
- BIOCORP
- bioCSL
- Biogen
- BioMatrix Specialty Pharmacy
- Biomedical Advanced Research and Development Authority
- BioMedical Drug Development
- BioNano Genomics
- Bioverativ
- Bleeding Disorders Foundation
- Blood Bank Of Delmarva
- Blood Centers of America
- Blood Systems
- Bluebird Bio
- BMG Pharmaceuticals
- Bonfils Blood Center
- Boryung Pharmaceutical
- Bristol-Myers Squibb
- Bristol-Myers Squibb Foundation
- C-Bridge Capital
- Cadila Pharmaceuticals
- Calbiotech
- California Institute for Regenerative Medicine
- Calithera Biosciences
- Capnia
- Cardiome Pharma
- Casebia Therapeutics
- Case Western Reserve University
- Catalyst Biosciences
- CEI
- Celgene
- Central California Blood Center
- Cerus
- Cesca Therapeutics
- Children's Hospital of Philadelphia
- Children's Minnesota
- China Biologic Products
- China Cord Blood
- Cincinnati Children's Hospital Medical Center
- CJ Corp
- Clinigen
- CMC Biologics
- Comercializadora BioRenal
- Cord Blood Registry
- Cordlife
- CRISPR Therapeutics
- CSL Behring
- CSL Plasma
- Cytonet
- CytoSorbents
- Daiichi Sankyo
- DaVita
- Defense Advanced Research Projects Agency
- Department of Health and Human Services
- Dimension Therapeutics
- Dova Pharmaceuticals
- Dr. Reddy's Laboratories
- Dr Franz Kohler Chemie
- Duke University
- Eagle Pharmaceuticals
- EMD Serono
- Emergent BioSolutions
- Emirates Gastroenterology & Hepatology Society
- EpiDestiny
- ERBA Diagnostics
- Ergomed
- Esperion Therapeutics
- European Medicines Agency
- Evonik Industries
- Evotec
- Expression Therapeutics
- Fibriant
- Fibrogen
- Fondazione Telethon
- Fortis Healthcare
- Fresenius Kabi Pharmaceuticals
- Fresenius Medical Care
- Gamida Cell
- Gateway Hemophilia Association
- GC Pharma
- GE Healthcare
- Gencia Biotech
- Genexine
- Genoptix
- GenTegra
- GenVec
- Genzyme
- Global Blood Disorder Foundation
- GNYHA Services
- Golden Meditech
- Government Scientific Source
- Greater New York Hospital Association
- Grifols
- Haemonetics Corporation
- HanAll Pharmaceuticals
- Harvard Medical School
- Healthcare Royalty Partners
- Helsinn Healthcare
- HemaCare
- Hemophilia Foundation of Southern California
- HEMORIO
- Henry Schein
- Heska
- Hologic
- Homology Medicines
- Horiba
- Horizon Pharma plc
- Immucor
- Immune Deficiency Foundation
- Incyte
- Inserm
- Inserm Transfert
- Institute for Genome Statistics and Bioinformatics
- Institute of Human Genetics
- Instrumentation Laboratory
- Intrinsic LifeSciences
- inviCRO
- Ionis Pharmaceuticals
- Irish Haemophilia Society
- Israeli Ministry of Industry and Commerce
- Israeli National Authority for Technological Innovation
- Jazz Pharmaceuticals
- Karolinska University Hospital
- Kiadis Pharma
- Kurin
- Kyoto University
- LabPro
- La Jolla Pharmaceutical
- Lee's Pharmaceutical
- LFB Biotechnologies
- LifeHealth
- Ligand Pharmaceuticals
- Lonza
- Loop Medical
- Mallinckrodt Pharmaceuticals
- Massachusetts Institute of Technology
- Masterlab
- Masters Speciality Pharma
- Mayo Clinic
- Medgenics
- Medial
- Medica
- MedImmune
- Meditrade
- Medline Industries
- Menarini
- Merus Labs International
- Metabasis Therapeutics
- MicroHealth
- Miraca Life Sciences
- Mitsubishi Tanabe Pharma
- Moberg Pharma
- National Center for Advancing Translational Sciences (NCATS)
- National Heart
- Lung and Blood Institute
- National Hemophilia Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- National Transfusiology Center
- NCPC GeneTech
- New York Blood Center
- Novartis
- NovImmune
- Novo Nordisk
- Nxstage Medical
- Octapharma
- OMRF
- OrSense
- Ortho-Clinical Diagnostics
- Otsuka
- Oxford BioMedica
- Palex Medical
- Pan American Cancer Treatment Centers
- PathoQuest
- Pathway Diagnostics
- PBM Capital Group
- Peking University
- Pfenex
- Pfizer
- Pfizer Japan
- Pharmacosmos
- PhaseBio Pharmaceuticals
- Pieris
- Portola Pharmaceuticals
- Premier Inc
- Promethera Biosciences
- Prophylix Pharma
- Protagonist Therapeutics
- Provepharm
- Qiagen
- Quotient Bioscience
- Regen BioPharma
- Research Center for Molecular Medicine of the Austrian Academy of Sciences
- rEVO Biologics
- Rhode Island Blood Center
- Rigel Pharmaceuticals
- Roche Diagnostics
- Rockwell Medical
- Roivant Sciences
- Romark Laboratories
- Royal College of Surgeons (Ireland)
- Royalty Pharma
- RPRD Diagnostics
- Sage Bionetworks
- Salix Pharmaceuticals
- Samsung Bioepis
- Sangamo BioSciences
- Sanofi
- San Raffaele Telethon Institute for Gene Therapy
- Saol Therapeutics
- Sayre Therapeutics
- SciClone Pharmaceuticals
- Science Foundation Ireland
- Scil Animal Care
- Sekisui Medical
- Selecta Biosciences
- Selexis
- Seventh Sense Biosystems
- Shanghai RAAS Blood Products
- Shionogi
- Shire Laboratories
- Shire Pharmaceuticals
- Sidero Bioscience
- Sigilon Therapeutics
- Small Business Innovation Research
- Sophia Genetics
- Spark Therapeutics
- Spectrum Pharmaceuticals
- Spindial
- SQI Diagnostics
- Stanford University
- Strides Arcolab
- SunCoast Blood Bank (SCBB)
- Supernus Pharmaceuticals
- Swedish Orphan Biovitrum
- Swiss Red Cross
- Swiss Transfusion SRC
- Sysmex America
- Takeda Pharmaceutical
- Targacept
- Tasly Pharmaceuticals
- Tasso
- Tennessee Hemophilia
- Terumo
- Thalassaemia International Federation
- The Medicines Company
- Thermo Fisher Scientific
- TNO Pharma
- Tokra Medikal
- Topas Therapeutics
- Turgut Ilaclari
- UCB
- Uniformed Services University of the Health Sciences
- University College Cork
- University of Bonn
- University of Maryland Baltimore
- University of Pittsburgh
- Unyts
- US Bioservices
- Velesco
- Velocity Pharmaceutical Development
- Verax Biomedical
- Versiti Blood Research Institute
- Vertex Pharmaceuticals
- Vifor Pharma
- Viking Therapeutics
- Vitesse Biologics
- Wanbang Biopharmaceuticals
- Washington University in St Louis
- Worcester Polytechnic Institute (WPI)
- Xenetic Biosciences
For more information about this report visit https://www.researchandmarkets.com/r/py6e0p
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.